C-reactive Protein Levels Among Individuals With COVID-19
NCT ID: NCT04373798
Last Updated: 2021-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1006 participants
OBSERVATIONAL
2020-05-04
2021-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Current recommendations of management of COVID-19 include large-scale tests for virus. Such tests reveal whether an individual is infected with the virus, however, the demonstration of virus per se has no prognostic value for the ensuing course of the COVID-19 disease. Publications of possible treatments strategies increase exponentially, while evidence of triage of the affected individuals is mainly based on the level of pulmonary affection as measured by the Oxygen saturation.
To inform decision making for which patients are to be hospitalized due to risk of developing more severe affection, this study addresses the question, whether triage may be performed with the aid of a simple CRP measurement.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
NCT05274373
Efficacy and Safety of a Protocol Using C-reactive Protein to Guide Antibiotic Therapy
NCT05841875
Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management
NCT04668170
Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia
NCT03146182
Long-Term Experience and Health Effects of COVID-19
NCT04477902
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suspected COVID-19
Individuals with symptoms who are seen at covid19 check points for covid19 diagnosis.
C-reactive protein
Measurement of CRP value from blood sample taken at covid19 check point (baseline).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C-reactive protein
Measurement of CRP value from blood sample taken at covid19 check point (baseline).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Signed, informed consent for blood test to be drawn for the Biobank
Exclusion Criteria
2. Direct admission from check point.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henning Bliddal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Henning Bliddal
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henning Bliddal, DMSc
Role: PRINCIPAL_INVESTIGATOR
The Parker Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Parker Institute, Frederiksberg Hospital
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APPI2-CV-2020-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.